Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
1.38M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
754K
-
Shares change
-
-112K
-
Total reported value, excl. options
-
$486K
-
Value change
-
-$28.1K
-
Number of buys
-
10
-
Number of sells
-
-9
-
Price
-
$0.65
Significant Holders of Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (APDN) as of Q3 2024
26 filings reported holding APDN - Applied DNA Sciences, Inc. - Common Stock, $0.001 par value as of Q3 2024.
Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (APDN) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 754K shares
of 1.38M outstanding shares and own 54.47% of the company stock.
Largest 10 shareholders include AMH Equity Ltd (515K shares), GEODE CAPITAL MANAGEMENT, LLC (107K shares), JANE STREET GROUP, LLC (73.4K shares), Atria Wealth Solutions, Inc. (20K shares), Baader Bank Aktiengesellschaft (20K shares), Tower Research Capital LLC (TRC) (10.2K shares), BlackRock, Inc. (5.07K shares), CITIGROUP INC (1.84K shares), NATIXIS (677 shares), and Belvedere Trading LLC (633 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.